Depreciation of ADC Therapeutics SA from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ADC Therapeutics SA quarterly and annual Depreciation in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • ADC Therapeutics SA Depreciation for the quarter ending 31 Dec 2025 was $1,000, a 100% decline year-over-year.
  • ADC Therapeutics SA Depreciation for the twelve months ending 31 Dec 2025 was $705,000, a 47% decline year-over-year.
  • ADC Therapeutics SA annual Depreciation for 2025 was $705,000, a 47% decline from 2024.
  • ADC Therapeutics SA annual Depreciation for 2024 was $1,334,000, a 12% increase from 2023.
  • ADC Therapeutics SA annual Depreciation for 2023 was $1,187,000, a 12% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ADC Therapeutics SA Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $705,000 $1,000 -$340,000 -100% 01 Oct 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 $1,045,000 $0 -$336,000 -100% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $1,381,000 $362,000 +$36,000 +11% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $1,345,000 $342,000 +$11,000 +3.3% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,334,000 $341,000 +$6,000 +1.8% 01 Oct 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 $1,328,000 $336,000 +$20,000 +6.3% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $1,308,000 $326,000 +$53,000 +19% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $1,255,000 $331,000 +$68,000 +26% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $1,187,000 $335,000 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $316,000 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $273,000 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $263,000 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1

ADC Therapeutics SA Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $705,000 -$629,000 -47% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $1,334,000 +$147,000 +12% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $1,187,000 +$127,000 +12% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $1,060,000 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.